Orthofix International | OFIX - Cost Of Sales

Stock Price
12.87
Daily Change
0.15 1.18%
Monthly
8.42%
Yearly
-0.69%
Q2 Forecast
12.04

Orthofix International reported $66.63M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Dexcom USD 466.9M 11M Dec/2025
EDAP TMS EUR 7.91M 1.31M Sep/2025
Globus Medical USD 290.47M 8.09M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
STAAR Surgical USD 14.06M 2.8M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Surmodics USD 9.49M 23.54M Jun/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Veracyte USD 39.28M 1.93M Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025